Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study

Seniha Senbayrak,Nuri Özkütük,Hakan Erdem,Isik Somuncu Johansen,Rok Čivljak,Ayse Seza Inal,Uner Kayabas,Ebru Kursun,Nazif Elaldi,Branislava Savic,Soline Simeon,Emel Yilmaz,Olga Dulovic,Derya Ozturk-Engin,Nurgul Ceran,Botond Lakatos,Oguz Resat Sipahi,Mustafa Sunbul,Mucahit Yemisen,Selma Alabay,Bojana Beović,Aysegul Ulu Kilic,Yasemin Cag,Melanie Catroux,Asuman Inan,Gorana Dragovac,Özcan Deveci,Recep Tekin,Hanefi Cem Gül,Gönül Şengöz,Katell Andre,Arjan Harxhi,Yves Hansmann,Serkan Oncu,Şükran Köse,Oral Oncul,Emine Parlak,Alper Sener,Gulden Yilmaz,Umit Savasci,Haluk Vahaboglu

Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study

2015

Background Tuberculous meningitis (TBM) caused by Mycobacterium tuberculosis resistant to antituberculosis drugs is an increasingly common clinical problem. This study aimed to evaluate drug resistance profiles of TBM isolates in adult patients in nine European countries involving 32 centers to provide insight into the empiric treatment of TBM.

Keywords:

Mycobacterium tuberculosis
Drug resistance
Tuberculous meningitis
Isoniazid
Meningitis
Tuberculosis
Pathology
Medicine
Retrospective cohort study
Medical microbiology
Immunology
Virology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations